UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 21, 2017
Accession Number:
Submission Type:
CIK:
0000882361
Company Name:
Aptose Biosciences Inc.
File Number:
333-221783